The PE Ratio as of November 2025 (TTM) for Ryvu Therapeutics S.A. (RVU.WA) is -4.71

According to Ryvu Therapeutics S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -4.71. This represents a change of -37.07% compared to the average of -7.48 of the last 4 quarters.

Ryvu Therapeutics S.A. (RVU.WA) Historical PE Ratio (quarterly & annually)

How has RVU.WA PE Ratio performed in the past?

The mean historical PE Ratio of Ryvu Therapeutics S.A. over the last ten years is -761.20. The current -4.71 PE Ratio has changed -38.12% with respect to the historical average. Over the past ten years (40 quarters), RVU.WA's PE Ratio was at its highest in in the September 2017 quarter at 239.63. The PE Ratio was at its lowest in in the December 2017 quarter at -87.96.

Ryvu Therapeutics S.A. (RVU.WA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ryvu Therapeutics S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ryvu Therapeutics S.A. (RVU.WA) Average PE Ratio

How has RVU.WA PE Ratio performed in the past?

The current PE Ratio of Ryvu Therapeutics S.A. (RVU.WA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ryvu Therapeutics S.A. (RVU.WA) PE Ratio vs. Peers

How is RVU.WA’s PE Ratio compared to its peers?

Ryvu Therapeutics S.A.’s PE Ratio is greater than Bioceltix S.A. (-32.63), greater than Captor Therapeutics Spolka Akcyjna (-6.53), less than Selvita S.A. (1.60K), less than Molecure S.A. (-4.15), greater than Bioton S.a. (-35.19), less than Poltreg S.A. (-4.61), less than Centrum Medyczne ENEL-MED S.A. (33.26), less than Scope Fluidics S.A. (7.02), less than Mabion S.A. (-3.37), less than Synthaverse S.A. (39.08),

Build a custom stock screener for Ryvu Therapeutics S.A. (RVU.WA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ryvu Therapeutics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ryvu Therapeutics S.A. (RVU.WA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ryvu Therapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.